OFI Invest Asset Management Acquires 37,571 Shares of Synopsys, Inc. $SNPS

OFI Invest Asset Management boosted its holdings in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 118.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 69,418 shares of the semiconductor company’s stock after buying an additional 37,571 shares during the period. OFI Invest Asset Management’s holdings in Synopsys were worth $30,965,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Sankala Group LLC acquired a new stake in Synopsys during the 4th quarter worth $25,000. Elevation Wealth Partners LLC lifted its stake in shares of Synopsys by 96.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after purchasing an additional 27 shares during the period. Caitong International Asset Management Co. Ltd acquired a new position in shares of Synopsys in the 4th quarter valued at $28,000. IMG Wealth Management Inc. bought a new position in shares of Synopsys in the 1st quarter worth $30,000. Finally, Atlas Capital Advisors Inc. bought a new position in shares of Synopsys in the 4th quarter worth $32,000. 85.47% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Citigroup upped their price objective on Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, May 28th. BNP Paribas Exane raised their target price on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a report on Thursday, May 28th. Robert W. Baird set a $558.00 target price on Synopsys in a research report on Thursday, May 28th. Needham & Company LLC reaffirmed a “buy” rating and issued a $580.00 price target on shares of Synopsys in a research note on Thursday, May 28th. Finally, Berenberg Bank set a $633.00 price target on shares of Synopsys in a research report on Wednesday, May 27th. Two investment analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $565.06.

Read Our Latest Analysis on SNPS

Synopsys Price Performance

SNPS opened at $411.75 on Friday. The stock has a market cap of $78.84 billion, a P/E ratio of 95.31, a P/E/G ratio of 2.42 and a beta of 1.23. Synopsys, Inc. has a 12 month low of $366.00 and a 12 month high of $626.24. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The company has a fifty day simple moving average of $426.49 and a 200 day simple moving average of $443.50.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. During the same period in the previous year, the firm earned $3.67 earnings per share. The company’s revenue was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, research analysts expect that Synopsys, Inc. will post 10.65 EPS for the current year.

Insider Buying and Selling

In other Synopsys news, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer directly owned 14,358 shares in the company, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by corporate insiders.

Key Stories Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.